BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191021
DTEND;VALUE=DATE:20191023
DTSTAMP:20260515T022816
CREATED:20190514T110507Z
LAST-MODIFIED:20190514T110507Z
UID:20716-1571616000-1571788799@www.pharmajournalist.com
SUMMARY:Highly Potent Active Pharmaceutical Ingredients USA (HPAPI) Conference
DESCRIPTION:SMi is delighted to announce its USA Highly Potent Active Pharmaceutical Ingredients conference coming to Boston on the 21th – 22th October 2019. \nThe inaugural HPAPI USA conference will explore how current technologies are streamlining the HPAPI industry with artificial intelligence and machine learning\, to improve risk assessment and validation. The latest emerging therapies will be discussed including bispecific antibodies\, oncolytic viral complexes and hormones. Will the super-high level 5 banding for these biologics prove effective or inept? Are current containment planning and solutions truly ensuing the health of workers? These questions will be answered along with unique insights including HPAPI manufacturing technologies. \nAttend the conference and join our networking platform with industry professionals to provide you with the expertise to overcome challenges. \nDISCUSSION HIGHLIGHTS: \nOncology Antibody-Drug Conjugates (ADC)\, the ongoing developments and the containment challenges imposed \nHow to correctly assess\, plan and implement the most cost-effective containment \nEmerging HPAPI therapies\, oncolytic viruses their potential and challenges \nAlternative HPAPI manufacturing technologies to reduce powder exposure and improving safety along with enabling continuous manufacturing \nThe reality of oncology ADC and HPAPI: are most drugs using ‘highly-potent’ to improve brand image? Has 50 years of ADC R&D for oncology with no cure shows signs of no promise? \nView the full agenda: www.hpapi-usa.com/PJwl
URL:https://www.pharmajournalist.com/event/highly-potent-active-pharmaceutical-ingredients-usa-hpapi-conference/
LOCATION:Sheraton Boston Hotel\, Boston USA\, United States
ORGANIZER;CN="SMi Group Limited":MAILTO:nhoward@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191022
DTEND;VALUE=DATE:20191025
DTSTAMP:20260515T022816
CREATED:20190806T094720Z
LAST-MODIFIED:20190806T094807Z
UID:21857-1571702400-1571961599@www.pharmajournalist.com
SUMMARY:Lab Asset & Facility Management In Pharma 2019
DESCRIPTION:The 2nd annual Lab Asset & Facility Management in Pharma summit is the only industry-led platform to join 120+ senior experts from Lab Operations\, Facility Management\, Lab Supplies and Procurement across pharma\, biotech\, CROs and research institutions. \n \nJoin your colleagues who are beginning to implement end-to-end asset management programs to optimize spend and gain better visibility of inventory and equipment lifecycles in order to maximize capital efficiency. \nAt the event\, you’ll delve into your core challenges\, including: \n\nHow to increase R&D productivity and avoid unnecessary downtime\nRevise the operating model for lab facility and asset supplies\nOptimize utilization of lab equipment and facility footprint\nExplore new technologies and IoT for asset monitoring and predictive maintenance\nExtend and manage your equipment lifecycle\nEvaluate your relationships and collaborations with OEMs\n\nDon’t miss out on this one of a kind meeting to engage with your peers and re-define best practice for tomorrow’s operations! \nTo learn more and to register online\, visit: https://ter.li/lafm-listing-home
URL:https://www.pharmajournalist.com/event/lab-asset-facility-management-in-pharma-2019/
LOCATION:The Westin San Diego\, 400 West Broadway\, San Diego\, CA\, 92101\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191022
DTEND;VALUE=DATE:20191025
DTSTAMP:20260515T022816
CREATED:20190924T120933Z
LAST-MODIFIED:20190924T120933Z
UID:22557-1571702400-1571961599@www.pharmajournalist.com
SUMMARY:2nd Targeted Protein Degradation Summit
DESCRIPTION:Finally Drug the “Undruggable” Through Targeted Protein Degradation.  Encapsulating the excitement of the field of protein degradation; The 2nd TPD Summit 2019 is the definitive\, comprehensive and industry-dedicated conference for the field of protein degradation – focused on optimizing target validation\, improving medicinal chemistry & rational design and ultimately accelerating the translation of selective\, bioavailable and effective protein degraders into clinical trials. \nWith 50+ speakers\, 40+ late-breaking case studies\, 3 dedicated streams\, 6 technical deep-dives & 400+ attendees\, TPD 2019 is the most comprehensive and the definitive guide for large pharma\, innovative biotech and leading academic researchers to capitalize on this emerging therapeutic class and make targeted protein degradation a blockbuster therapeutic approach that improves patient outcomes. \nAs the previously untapped drug discovery opportunity promised within the proteome becomes a reality and “undruggable” targets are finally being reached\, the field of targeted protein degradation is truly changing the face of small molecule drug discovery. In the pursuit to demonstrate safe and effective clinical results\, it’s clear that a set of unique development challenges must be overcome for these novel therapeutics to achieve their seemingly limitless potential. \nView the program and speaker list here: https://ter.li/idctdn
URL:https://www.pharmajournalist.com/event/2nd-targeted-protein-degradation-summit/
LOCATION:Hilton Boston Logan Airport\, One Hotel Drive\, Boston\, MA\, 02128\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR